Ishan Hospital Intensive Care Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 7 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -46.34%
- Profit Growth -87.35%
- Ebitda -30.69%
- Net Worth -23.46%
- Total Assets -32.75%
About Ishan Hospital Intensive Care
Ishan Hospital Intensive Care Private Limited (IHICPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 November 2017 (Seven years and two months 19 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Monu Jindal and Shilpa Rani serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U93000DL2017PTC326127
-
Company No.
326127
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
17 Nov 2017
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Ishan Hospital Intensive Care?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Monu Jindal
|
Additional Director | 13-Jun-2022 | Current |
|
Shilpa Rani
|
Additional Director | 13-Jun-2022 | Current |
Financial Performance of Ishan Hospital Intensive Care.
Ishan Hospital Intensive Care Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 46.34% decrease. The company also saw a substantial fall in profitability, with a 87.35% decrease in profit. The company's net worth observed a substantial decline by a decrease of 23.46%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ishan Hospital Intensive Care?
In 2020, Ishan Hospital Intensive Care had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Orgits Business Solutions Private LimitedShilpa Rani is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ishan Hospital Intensive Care?
Unlock and access historical data on people associated with Ishan Hospital Intensive Care, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ishan Hospital Intensive Care, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ishan Hospital Intensive Care's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
